Your new post is loading...
Your new post is loading...
Insights from Big data and partnerships among medtech companies, insurers and health systems will drive the success of value-based care.
Via Dominique Godefroy
ConclusionsThe cyber-physical debate nexus, which connects the cyber narrative in social media to the corresponding geographical space, allows the study of the public’s concerns, views, and responses to health-related issues and thus offers a new avenue for exploring health narratives. As these new mechanisms of discourse are emerging, health communications and health informatics have to adapt to these newfound capabilities and challenges. Advancing our understanding of the mechanisms and patterns of communication in these media is therefore becoming increasingly important. Toward this goal, this study showcased emerging data analysis approaches. These approaches are inherently interdisciplinary, bringing together principles and practices from health informatics, data analytics, and geographical analysis. Further coalescing such capabilities will advance health communication, supporting the design of more effective strategies that take into account public perceptions and concerns. At the same time, we need to remain cognizant of privacy issues associated with the nature of social media communications. Studying the narrative rather than the individuals and aggregating data in geographical spaces can maintain the relevance of the analysis while also preserving user anonymity.
Dr. Kevin Campbell
Increasingly, we use social media to research our medical conditions, the drugs and vitamins we take, our doctors, specialists and hospitals. At the same time, regulators such as the Food and Drug Administration (FDA) attempt to protect the patient-consumer with a series of rules and regulations that govern the communications of organizations providing health related products and services to the public. Or does it?
If you are like me, your cabinets are filled with vitamins and dietary supplements. They are all “healthy”, right? Well maybe not. It turns out that supplements “are the ‘Wild, Wild West’ in terms of regulation” according to Dr. Kevin Campbell. Dr. Campbell is an internationally recognized Cardiologist who specializes in the diagnosis and treatment of heart rhythm disorders. Dr. Campbell is the Medical Expert for WNCN and appears weekly on the NBC17 morning news and also makes frequent appearances nationally on Fox News and CBS. Unlike many physicians, he is an enthusiastic user of social media and you can follow him on Twitter @DrKevinCampbell. Below is an edited version of our latest discussion that occurred over the phone and email.
Belbey: Could you describe supplements, how they differ from pharmaceuticals and how they are regulated?
Dr. Campbell: Dietary supplements contain substances that are naturally occurring and cannot be synthetic in any way. Pharmaceuticals can be natural compounds with man-made compounds. These two substances are regulated by the Food and Drug Administration (FDA) very, very differently. For supplements, you just need to show that your labeling accurately reflects what is in the powder, pill, or bottle. On the other hand, with pharmaceuticals, must prove both safety and efficacy before they come to market. You start with animal models and you need to push it all the way through to Phase 3 clinical trials where you’re actually working in humans. You must show with certainly that benefit outweighs risk. Plus, post marketing surveillance (or gathering information once the product is released) is significant in pharmaceuticals. However, with supplements, rather than making companies conduct post market data collection and trials, supplements rely on the consumer to report any adverse effects to the FDA. If the FDA gets enough comments on a particular supplement, they may choose to act at that time.
Belbey: In short, FDA regulatory requirements are very different between supplements and pharmaceuticals?
Dr. Campbell: Supplements are the “Wild Wild West” in terms of regulation , whereas I consider pharmaceuticals over-regulated. It’s two wide extremes. I’d like to see something more in the middle with more regulation of supplements to protect the consumer and more meaningful streamlined regulatory action on the pharmaceutical industry. For example, in my opinion, when we have a medicine that has been proven to be safe and effective and has a change in packaging, the pharmaceutical firms shouldn’t have to go through whole lengthy process for approval. We need to create a fast track for drugs that could potentially have an immediate impact, such as life-saving cancer drugs, or some of the new drugs for Hepatitis C, for example.
Tristan Debove, Country Sales Manager chez InterSystems, a répondu à quelques questions relatives aux objets connectés dans le milieu de la santé. Il nous livre des pistes d’utilisation concrète et revient sur les solutions développées par les partenaires Intersystems, mais également par l’éditeur lui-même.
Via Bruno Demay, Philippe Marchal
La labellisation des objets connectés est aujourd'hui un enjeu fort pour aider les consommateurs à faire la différence dans un marché où de nombreux outils apparaissent tous les jours. Meddappcare* et Ag2r La Mondiale ont souhaité interroger les Français afin de mesurer leur confiance dans ces nouveaux produits, connaître leur intérêt vis-à-vis d’un tel label et estimer la place des mutuelles et des assurances santé sur ce marché
Via Dominique Godefroy, Philippe Marchal
Linus è solo uno degli ultimi personaggi pubblici ad abbandonare quel modo spesso innocente e sincero di comunicare con il proprio pubblico. Meno rischioso stare sul bidimensionale Instagram.
Quella che andiamo a raccontare probabilmente non è una vera e propria notizia, però ci permette di fare alcune considerazioni su celebrità e comunicazione, social media e haters. La non-notizia è che Linus, direttore artistico di Radio Deejay, ha deciso di abbandonare il proprio blog personale contenuto all’interno del sito del network radiofonico. Lo ha fatto attraverso un videopost intitolato Arrivederci in cui spiega le motivazioni di questa decisione: “Mi mancherà come occasione per raccontare cose di me che non dico a nessuno” racconta Linus davanti alla telecamera “Ma odio questa sensazione da giorno della marmotta, il continuare a ricalcare un cliché, e poil’imbarbarimento nel commento dell’attualità che genera polemiche antipatiche”. Poi continua: “Come tutti sto diventando grande (vecchio), quindi come per tutti aumentano gli acciacchi fisici e nervosi e ho notato nella mia scrittura emergevano sopratutto questi”.
True Wearables, Inc., a medical device start-up based in Orange County, CA, announced today Oxxiom, the world's first wireless, continuous, fully disposable, single-use pulse oximeter. Oxxiom measures arterial oxygen saturation (SpO2), pulse rate (PR), and perfusion index (PI). True Wearables' innovative design has combined the electronics and biosensing technology of a clinical grade pulse oximeter into a tiny, easy-to-use, and completely wireless device that offers over 24 hours of continuous monitoring. Oxxiom weighs only 0.12 ounces (3.5 grams) and is completely disposable, eliminating the need for sterilization and significantly reducing the risks of cross contamination.
Health literacy must be considered during patient information leaflet development, as it can make a difference and improve patient lives.
Let’s begin with a question. When it comes to assembling flat-pack furniture, are you an ‘instruction follower’, or do you prefer to work it out for yourself?If you’re the latter, it’s most probably because you find instructions impossible to understand. What’s the worst that can happen if you get it wrong, anyway? You either have to start again, or make do with a less-than-perfect chest of draws.
Sadly, however, failure to follow patient information leaflets (PILs) can carry a much higher price. These may sound like strong words, but consider all the people who haven’t the time or capacity to read PILs properly. Failure to understand how and when to take medication, or how important it is, can have results which are far more disastrous than a wobbly chair. At best, the therapies won’t ease or cure symptoms, and at worst they can aggravate illnesses, produce harmful side-effects and even fatalities.
Via COUCH Medcomms
The results of this year’s mHealth App Developer Economics 2016 study show a steep increase in competition level among mHealth app publishers. The supply side of mHealth apps is measured in the number of available apps and publishers. They are growing significantly faster than the demand side which is quantified by the number of mHealth app downloads.
The number of mHealth apps and active mHealth app publishers has seen strong growth since 2015. This year, the total number of mHealth apps listed on major app stores across the globe grew by 57% to 259,000 apps. This impressive growth is based on three main developments; the growing number of mHealth app publishers, the increased importance of multi-platform app publishing and the expansion of existing mHealth app portfolios.
The number of mHealth app publishers grew in line with the number of apps. There are currently 58,000 mHealth app publishers app on major app stores, 28% more since the beginning of 2015. There appears to be no immediate end to the number of companies rushing into the market to launch their first mHealth app.
In contrast, growth rates of mHealth app store downloads are estimated to be only +7% in 2016, having been +35% the previous year, reaching a total of 3.2B in 2016. This is in line with other app market categories and reflects the fact that growth of capable devices that can download apps has slowed down in most western countries.
As a consequence of this increased competition, it will be even more difficult to stand out and gain significant downloads. Only 14% of mHealth app publishers generated more than 100,000 downloads with their mHealth app portfolio in one year.
With hundreds of new mHealth apps released daily, companies have to consider their app launch as if it were a familiar product in a saturated market.
Via Pharma Guy
Singapour– Nouveau revers pour les bracelets d’activité. Une étude révèle que proposer à des salariés plein temps d’utiliser régulièrement un dispositif connecté pendant 6 mois, même avec des incitations financières, ne permet d’augmenter que légèrement le niveau d’activité des participants (16 minutes par semaine), et pas assez pour entrainer des améliorations en termes de santé (sur le poids, la pression artérielle,…). De plus, à 1 an (soit 6 mois après l’arrêt des incitations financières), 90% des participants avaient remisé leurs bracelets connectés au placard, selon un essai randomisé ayant inclus 800 travailleurs à plein temps et publié dans The Lancet Diabetes & Endocrinology.
4 groupes dont 2 recevant des incitations financières
Les bracelets d’activité chargés de suivre et d’enregistrer l’activité physique (activity tracker) ne sont visiblement pas – tout du moins dans leur version actuelle – la panacée espérée pour lutter contre la sédentarité et enrayer l’épidémie d’obésité. Deux semaines après une publication dans le JAMA  qui montrait qu’ils étaient inefficaces sur la perte de poids, voire même contreproductifs par rapport à un coaching direct (voir encadré), une nouvelle étude confirme le peu d’intérêt de ces dispositifs connectés pour influer sur la pratique sportive à long terme, et montre (et c’est là l’originalité du travail) qu’une incitation financière ponctuelle en pièces sonnantes et trébuchantes ne constitue pas une motivation suffisante pour maintenir l’effort dans le temps.
From fitness trackers to medical devices that track specific conditions such as Huntington's disease or asthma, technology and healthcare companies are increasingly joining forces to utilize the Internet of Things to better monitor patients' health and help prevent diseases.
The possibilities for both device makers and Big Pharma to collaborate with tech companies are vast, which is no surprise given that more than $3 trillion was spent on healthcare in the U.S. in 2014, and likely even more than that in 2015, according to the Centers for Medicare & Medicaid Services.
Alongside countless digital health startups, a wave of collaborations has already taken place as companies look to get ahead of what remains a very ill-defined market. But these new opportunities aren't without risk, and for device makers and other healthcare companies, that uncertainty is largely centered around security.
mHealth technology helps providers reach their patients between office visits, helping to drive robust patient engagement.
mHealth is an important tool for improving patient engagement because so much of the technology is already consumer-facing. From fitness trackers and patient portals to smartphone apps and home monitoring equipment, mHealth permeates patients’ everyday lives.
When these tools are easily available through a smartphone or a wearable sensor on a wrist, they can ideally lead patients to monitor their health and even interact with their providers every day.
mHealth can also be used for remote patient monitoring and telemedicine, which help patients access care in a way that is convenient for them, opening doors to care encounters that may have been more difficult to reach.
Below, PatientEngagementHIT.com breaks down the role of mHealth technology in patient engagement, reviewing different kinds of tools and how they enhance the patient experience.
Supply of mobile health apps greatly exceeds the demand for them, based on research2guidance’s report on the mHealth App Developer Economics 2016, analyzing the status and trends of the mobile health apps market. This is research2guidance’s sixth annual study on the topic.
The number of mHealth apps in app stores has reached some 259,000 in 2016. The growth rate of the demand for apps has fallen to 7 percent in 2016 after growing 35 percent in 2015.
It’s not a money-making enterprise for the vast majority of mHealth app publishers, 60 percent of whom earned less than $1,000 per month from their app portfolios. The highest price threshold for which a consumer would be willing to pay out-of-pocket for an mHealth app is $10, research2guidance estimates.
Doctors will now have to be more careful on what is posted online and look into their personal branding on social media platforms, said a new ethical guidelines by the Singapore Medical Council (SMC) which revised its Ethical Code and Ethical Guidelines (ECEG). The last revision was in 2002.
The new guidelines which covers more than just social media conduct, serves as an update to address increasing complexities of the medical practice in light of technological changes and advancements.
The ECEG comes with examples listing the entire range of possible inappropriate behavior on social media such as appearing intoxicated, engaging in lewd or inappropriate behavior, posting personal or derogatory comments about patients or colleagues, to name a few.
Michael Banner, general manager at McCann Health, said the new guidelines are in line with the increasing digitisation of healthcare. He added that social media, an element of digitisation, is something which is already an integral part of the patients’ personal and professional life and will naturally form a component of a patient’s relationship with their trusted advisors, which includes healthcare professionals.
However, the right to medical privacy needs to supersede all else when it comes to health digitisation. According to Banner, this is a particular challenge when it comes to building digital solutions for healthcare clients in APAC where each country has their own unique code of conduct.
“When a doctor’s personal Whatsapp-account is doubling up as their professional account it’s a recipe for disaster,” Banner said, adding that another area that will require more detailed guidelines is doctor-to-doctor use of social media to share and discuss patient information in a secure and ethical manner.
According to Kiran Aswani, business head at iris Worldwide, the move to address social media conduct is something which is natural given that the last time the guidelines were revised was in 2002.
“A lot has progressed in the healthcare industry since then, including the proliferation of social media into our daily lives and democratisation of healthcare,” Aswani said.
She added that having the guidelines will ensure there is more conscious approach to the healthcare conversations that are taking place online. It also avoids potential avenues for misunderstandings of medical conditions and any inaccurate treatment recommendations to occur due to physical absence of the patient.
“This is especially important in a country such as Singapore where healthcare environment is regulated keeping in mind welfare of the people. It is crucial to ensure that people are conscious about promoting the right healthcare versus the drug and consultations,” Aswani said.
New communications technology has the potential to both disrupt and enhance the pharmaceutical industry, but research shows that pharma often needs to up its game when it comes to the adoption of new technologies.
Mobile devices have transformed how we access and consume content, and are poised to make similarly huge changes to the way consider our health (read “The mHealth App Market is at the Saturation Point”; http://sco.lt/5thWGv). mHealth revenue is projected to reach 26 billion by 2017, and the number of health apps has doubled in just the past two years. Social is also likely to have a major impact in the way that pharma communicates in the coming years. 52% of physician’s surveyed by Deloitte in this research expressed interest in communicating with pharma companies via social media.
However, pharma currently lags behind other verticals for using social media. Pharma spending on digital advertising is far below that of other industries, and it still conducts most of it’s communications with physicians via traditional channels. There is big potential for new communications technology to make the pharmaceutical industry more efficient and more engaged with it’s customers. This infographic from Deloitte shows the potential for new digital technology to allow pharma to market itself more effectively.
Via Pharma Guy, Lionel Reichardt / le Pharmageek
The Institute of Medicine recently highlighted that physician diagnostic error is common and information technology may be part of the solution.1 Given advancements in computer science, computers may be able to independently make accurate clinical diagnoses.2 While studies have compared computer vs physician performance for reading electrocardiograms,3 the diagnostic accuracy of computers vs physicians remains unknown. To fill this gap in knowledge, we compared the diagnostic accuracy of physicians with computer algorithms called symptom checkers.
Asmartphone app that can tell if users are in danger of having a heart attack by the tone of their voice is being considered for use by the NHS.
Clinical trials of the software showed it accurately predicted admission to hospital for people with congestive cardiac failure one week before they were taken gravely ill.
The app is one of a wealth of gadgets and systems under review by the health service with the aim of revolutionising personalised healthcare.
Did you know that nine out of ten people aged 18-24-year-old trust medical information shared via social media? Given the amount of misinformation, hoaxes and urban legends that go viral on social media, those stats are enough to give any doctor pause. The advent of the digital age means faster access to information.
That’s all well and good, but it comes with a big problem: not all information is created equal. Getting access to accurate, complete and up-to-date healthcare information, and then knowing how to interpret this information, is the real challenge. Take WebMD, for example. While WebMD can be a useful tool for learning about medical conditions, it’s also given rise to an epidemic of inaccurate self-diagnosis.
Increasingly, medical practices are adopting an attitude of “if you can’t beat them, join them.” That’s good news for a practice’s bottom line, too: Four out of 10 people say social media influences their choice of a doctor or hospital, according to ReferralMD.
Getting active on social media is as important for reaching new patients as it is for connecting with existing ones. Social media is also a vital part of effective multi-channel marketing, says marketing expert Dan Goldstein, who advises medical professionals on marketing best practices.
Is your medical practice guilty of ignoring social media? From patient education to building your personal brand, social media marketing is a must-do for health care professionals. That said, just because you tweet a few times doesn’t mean your patients will take notice. Follow these tips to jumpstart your social media marketing:1. Know your audience
Your audience includes patients, caregivers, and your fellow medical providers. Audience roles are fluid: patients can become caregivers and doctors can become patients. Your social media posts will need to engage with all these different audience members.
As a result, the messages you develop will differ based on which social media channel you’re using and which audience subset you’re targeting. Before launching a social media campaign, take the time to understand the different needs and motivators of your audience members, and shape your content accordingly.2. Be relevant
Use seasonal trends as a “hook” for your content. In January, New Year’s Resolution themed content such as preventative health care, weight loss/nutrition tips, and mindfulness is popular. Come summer, use the warmer months to promote sun safety and skin cancer awareness. Don’t ignore current events, either. From the latest on the Zika virus to last year’s Disneyland measles outbreak, keep on top of current health news as it breaks.
Set up Google alerts to monitor news closest to your practice’s services and your audience’s interests. Be prepared to move fast; with the half-life of a tweet averaging 18 minutes, timeliness and relevancy is everything. However, in the rush to get on top of a story, watch out for click-bait headlines. It’s a practice Facebook is now penalizing, and one social media users in general detest.3. Engage your audience
To be an authentic voice in the healthcare conversation, you need to take time out and listen to what your audience is talking about before you start adding your two cents to the conversation. Audience engagement means allowing space for others to share their stories. It also means being responsive.
While you should not give personal medical advice over social media, you can answer medical questions with a professional and compassionate tone. Even if the response is a recommendation to set up an appointment with a medical provider, a prompt response lets your audience know you value what they have to say and care enough to connect.4. Maintain industry compliance
As a heavily regulated industry, medical providers face a host of rules and regulations governing healthcare communications, including HIPPA, ACA, and ERISA. A good rule of thumb: never provide specific medical advice to a patient via social media.
Instead, share general information in response to a social media medical question and encourage the patient to contact your practice directly for a personal (and private) consultation. Remember, anything you say on social media can last forever, so watch what you post. Tweets may fade away into the Twittersphere after 18 minutes, but the record is always there. Even if you delete social media content, someone may have captured a screenshot. Think before you tweet!Bottom line:
Social media is a powerful means for giving your practice a voice and connecting with your audience on the issues they care most about.
As you refine your social media strategy, note which types of content perform best (infographics or short videos?), which times your audience is most responsive (Saturday afternoon or Wednesday evening?), and which channels they prefer for communications (Facebook or Twitter?).
By connecting with the right people at the right time about the right healthcare issues, you’ll grow your social media audience and strengthen your practice’s brand, too.
L'étude des médicaments « dans la vraie vie » permet de détecter des effets indésirables qui n'auraient pas été mis en évidence lors des essais précédant leur mise sur le marché. Cela s'explique par le fait que les essais portent, nécessairement, sur un nombre limité de personnes. C'est pourquoi il est demandé aux médecins, aux pharmaciens et aussi aux patients de déclarer les problèmes rencontrés avec un traitement. Pour aller plus loin, des chercheurs étudient maintenant la possibilité d'analyser les contenus des réseaux sociaux ou des forums à la recherche de cette précieuse information. L'Académie nationale de pharmacie y consacre une séance cet après-midi.
Every year, R2G (Research 2 Guidance) delivers a very detailed analysis about the mHealth app market.This year, the report gives special attention to the role of health insurance companies in the global mHealth app market. In addition it gives an update on the overall market size including number of apps, publishers, new entries, revenues and downloads.
Via Philippe Marchal
"What we want to do then is, using big data and other technologies, incorporate [the machines] into wellness programs so that you can be rewarded for repeat purchases that you make of healthy food coming out of these. You could potentially leverage some of the reward points through your wellness programs to actually redeem free food in there."